Quality of life of chronic heart failure patients: a systematic review and meta-analysis
- PDF / 1,319,524 Bytes
- 14 Pages / 595.276 x 790.866 pts Page_size
- 90 Downloads / 221 Views
Quality of life of chronic heart failure patients: a systematic review and meta-analysis Mandana Moradi 1 & Fereshteh Daneshi 2 & Razieh Behzadmehr 3 & Hosien Rafiemanesh 4 & Salehoddin Bouya 5 & Mohammad Raeisi 6
# Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract Despite various individual studies on the quality of life (QOL) in patients with CHF, a comprehensive study has not yet been conducted; therefore, this study aims to assess the QOL of CHF patients. In the present systematic review and meta-analysis, PubMed, Scopus, and the Web of science databases were searched from January 1, 2000, to December 31, 2018, using QOL and heart failure as keywords. The searches, screenings, quality assessments, and data extractions were conducted separately by two researchers. A total of 70 studies including 25,180 participants entered the final stage. The mean QOL score was 44.1 (95% confidence interval (CI) 40.6, 47.5; I2 = 99.3%) using a specific random effects method in 40 studies carried out on 12,520 patients. Moreover, according to the geographical region, heart failure patients in the Americas had higher scores. In 14 studies, in which a general SF-36 survey was implemented, the average physical component score (PCS) and mental component score (MCS) were 33.3 (95% CI 31.9, 34.7; I2 = 88.0%) and 50.6 (95% CI 43.8, 57.4; I2 = 99.3%), respectively. The general and specific tools used in this study indicated moderate and poor QOL, respectively. Therefore, it is necessary to carry out periodic QOL measurements using appropriate tools as part of the general care of CHF patients. Keywords Heart failure . Quality of life . Meta-analysis
Introduction Today, chronic heart failure (CHF) is a serious global health challenge. According to the most recent 2019 data, more than Electronic supplementary material The online version of this article (https://doi.org/10.1007/s10741-019-09890-2) contains supplementary material, which is available to authorized users. * Salehoddin Bouya [email protected] 1
Clinical Pharmacy Department, School of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran
2
Department of Pediatric Nursing, School of Nursing and Midwifery, Jiroft University of Medical Sciences, Jiroft, Iran
3
Associate Professor of Radiology, Department of Radiology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
4
Student Research Committee, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5
Internal Medicine and Nephrology, Clinical Immunology Research Center, Ali-ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran
6
Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran
6.2 million people in the USA are afflicted with CHF, which is projected to reach over 8 million by 2030 [1]. World Health Statistics from 2012 alone show that heart failure (HF) has created an additional burden of 180 million dollars in the health system [2]. Different physical and mental comp
Data Loading...
